
Prantae Solutions is a medical device and in-vitro diagnostic development company focused on revolutionizing healthcare through innovative, user-friendly, and accessible point-of-care diagnostic solutions. They leverage cutting-edge technology, including IoT and IoE software, AI/ML, and advanced sensing capabilities, to detect microscopic changes in biomarkers. Their product portfolio includes Proflo-U® for kidney care (albumin, creatinine, uACR measurement), Eyera Sense® for precise biomarker detection, and Embargo® COVID-19 diagnostic kits. Prantae emphasizes a design-centric approach, integrating Human Factors Engineering for intuitive interfaces and aiming to provide early diagnosis and personalized care, making healthcare more efficient and equitable globally. They have obtained CDSCO licenses and ICMR approvals for their diagnostic kits.

Prantae Solutions is a medical device and in-vitro diagnostic development company focused on revolutionizing healthcare through innovative, user-friendly, and accessible point-of-care diagnostic solutions. They leverage cutting-edge technology, including IoT and IoE software, AI/ML, and advanced sensing capabilities, to detect microscopic changes in biomarkers. Their product portfolio includes Proflo-U® for kidney care (albumin, creatinine, uACR measurement), Eyera Sense® for precise biomarker detection, and Embargo® COVID-19 diagnostic kits. Prantae emphasizes a design-centric approach, integrating Human Factors Engineering for intuitive interfaces and aiming to provide early diagnosis and personalized care, making healthcare more efficient and equitable globally. They have obtained CDSCO licenses and ICMR approvals for their diagnostic kits.